Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01278966
Other study ID # S-09180a (REK)
Secondary ID
Status Completed
Phase N/A
First received December 29, 2010
Last updated January 17, 2011
Start date May 2009
Est. completion date December 2010

Study information

Verified date December 2010
Source Oslo University Hospital
Contact n/a
Is FDA regulated No
Health authority Norway:National Committee for Medical and Health Research Ethics
Study type Interventional

Clinical Trial Summary

The purpose of the study is to evaluate the effect of the Modified Atkins Diet in children and adolescents with drug-resistant epilepsy regarding seizure control, and to create a protocol for the use of the Modified Atkins Diet as a treatment for epilepsy in Norway.


Description:

The study is a prospective trial on the Modified Atkins Diet for children and adolescents with drug-resistant epilepsy. The Modified Atkins Diet is a less restrictive diet than the classical ketogenic diet, which is usually offered to this group of patients. Twenty patients between 2 and 18 years are included in the study, and the study period is 6 months. The study will be conducted at the National Centre for Child Epilepsy in Norway.


Recruitment information / eligibility

Status Completed
Enrollment 21
Est. completion date December 2010
Est. primary completion date December 2010
Accepts healthy volunteers No
Gender Both
Age group 2 Years to 18 Years
Eligibility Inclusion Criteria:

- age: 2-18 years

- At least 3 epileptic seizures per week

- Tried at least two anti-epileptic drugs without satisfactory seizure control

- Willing to try diet treatment for 6 months

Exclusion Criteria:

- Too difficult for the family to adhere to a strict diet

- Not able to fill in a seizure calendar

- Local authorities will not approve the treatment

- VNS stimulator the last 12 months or changes made to VNS stimulator during the last three months

- Other disease where a diet high in fat is contra indicated

- Diet treatment is not possible because of poor intake of food or fluids

- Cortisol or other medication that influence energy metabolism or epileptic drug metabolism last month

- Patient has the last month used alternative medicine which may influence the diet

- Patient has tried the ketogenic fiet og Modified Atkins diet the last three years

- pregnancy

Study Design

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Other:
The Modified Atkins Diet
The Modified Atkins Diet; 10 g carbohydrate per day and a high fat intake

Locations

Country Name City State
Norway The National Centre for Child Epilepsy Pb. 53 Bærum Postterminal

Sponsors (1)

Lead Sponsor Collaborator
Oslo University Hospital

Country where clinical trial is conducted

Norway, 

Outcome

Type Measure Description Time frame Safety issue
Primary Seizure frequency Seizure frequency is assessed after 1 month, 3 months and 6 months. 6 months No
Secondary Ambulatory EEG 24-hours EEG before diet treatment and after 6 months on the diet. After 6 months No
Secondary Body Weight Body weight was measured before diet treatment, after 1 month, 3 months and 6 months. 6 months No
Secondary Quality of life Questionnaire assessing quality of life and life on a strict diet, assessed after one, three and six months. 6 months No
Secondary Ketosis Ketosis in blood and urine measured during the whole study period 6 months No
Secondary Dietary records 3-days dietary records were obtained after two and ten weeks on the diet. 10 weeks No
See also
  Status Clinical Trial Phase
Completed NCT04595513 - Stopping TSC Onset and Progression 2: Epilepsy Prevention in TSC Infants Phase 1/Phase 2
Completed NCT02909387 - Adapting Project UPLIFT for Blacks in Georgia N/A
Completed NCT05552924 - Self Acupressure on Fatigue and Sleep Quality in Epilepsy Patients N/A
Terminated NCT01668654 - Long-term, Open-label Safety Extension Study of Retigabine/Ezogabine in Pediatric Subjects (>= 12 Years Old) With POS or LGS Phase 3
Not yet recruiting NCT05068323 - Impact of Interictal Epileptiform Activity on Some Cognitive Domains in Newly Diagnosed Epileptic Patients N/A
Completed NCT03994718 - Creative Arts II Study N/A
Recruiting NCT04076449 - Quantitative Susceptibility Biomarker and Brain Structural Property for Cerebral Cavernous Malformation Related Epilepsy
Completed NCT00782249 - Trial Comparing Different Stimulation Paradigms in Patients Treated With Vagus Nerve Stimulation for Refractory Epilepsy N/A
Completed NCT03683381 - App-based Intervention for Treating Insomnia Among Patients With Epilepsy N/A
Recruiting NCT05101161 - Neurofeedback Using Implanted Deep Brain Stimulation Electrodes N/A
Active, not recruiting NCT06034353 - Impact of Pharmacist-led Cognitive Behavioral Intervention on Adherence and Quality of Life of Epileptic Patients N/A
Recruiting NCT05769933 - Bridging Gaps in the Neuroimaging Puzzle: New Ways to Image Brain Anatomy and Function in Health and Disease Using Electroencephalography and 7 Tesla Magnetic Resonance Imaging
Not yet recruiting NCT06408428 - Glioma Intraoperative MicroElectroCorticoGraphy N/A
Not yet recruiting NCT05559060 - Comorbidities of Epilepsy(Cognitive and Psychiatric Dysfunction)
Completed NCT02646631 - Behavioral and Educational Tools to Improve Epilepsy Care N/A
Completed NCT02952456 - Phenomenological Approach of Epilepsy in Patients With Epilepsy
Completed NCT02977208 - Impact of Polymorphisms of OCT2 and OCTN1 on the Kinetic Disposition of Gabapentin in Patients Undergoing Chronic Use Phase 4
Recruiting NCT02539134 - TAK-935 Multiple Rising Dose Study in Healthy Participants Phase 1
Completed NCT02491073 - Study to Evaluate Serum Free Thyroxine (FT4) and Free Triiodothyronine (FT3) Measurements for Subjects Treated With Eslicarbazeine Acetate (ESL) N/A
Terminated NCT02757547 - Transcranial Magnetic Stimulation for Epilepsy N/A